TONGXINLUO PRETREATMENT ENHANCES THERAPEUTIC EFFICACY OF MESENCHYMAL STEM CELLS AFTER ACUTE MYOCARDIAL INFARCTION POSSIBLY VIA UPREGULATING HYPOXIA INDUCIBLE FACTOR 1α

Tongxinluo (TXL), a widely used traditional Chinese medicine in cardiovascular diseases, has anti-inflammatory and anti-apoptosis effects. However, no studies have explored whether translanted bone-marrow-derived mesenchtmal stem cells pretreated by TXL (MSCTXL) can enhance survival of MSCs thus